Cigna Corporation (CI): Price and Financial Metrics
Cigna Corporation (CI)
Today's Latest Price: $202.39 USD
Updated Jun 4 4:10pm
Add CI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
CI Stock Summary
- With a market capitalization of $74,298,010,938, Cigna Corp has a greater market value than 97.67% of US stocks.
- CI's went public 34.45 years ago, making it older than 92.85% of listed US stocks we're tracking.
- As for revenue growth, note that CI's revenue has grown 104.86% over the past 12 months; that beats the revenue growth of 94.66% of US companies in our set.
- Stocks that are quantitatively similar to CI, based on their financial statements, market capitalization, and price volatility, are ANTM, BKNG, MDLZ, EL, and AXP.
- CI's SEC filings can be seen here. And to visit Cigna Corp's official web site, go to www.cigna.com.
CI Stock Price Chart More Charts
CI Price/Volume Stats
| Current price | $202.39 | 52-week high | $224.64 |
| Prev. close | $201.36 | 52-week low | $118.50 |
| Day low | $198.46 | Volume | 1,259,242 |
| Day high | $204.40 | Avg. volume | 2,380,015 |
| 50-day MA | $185.98 | Dividend yield | 0.02% |
| 200-day MA | $183.81 | Market Cap | 74.68B |
Cigna Corporation (CI) Company Bio
Cigna Corporation offers medical, dental, disability, life and accident insurance and related products and services. The Company operates in three segments: Global Health-Care, Global Supplemental Benefits and Group Disability and Life. The company was founded in 1792 and is based in Bloomfield, Connecticut.
CI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $202.39 | $624.13 | 210% |
We started the process of determining a valid price forecast for Cigna Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cigna Corp ranked in the 72th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 211.5%. In terms of the factors that were most noteworthy in this DCF analysis for CI, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 67. Its equity weight surpasses that of merely 21.67% of free cash flow generating stocks in the Healthcare sector.
- Cigna Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 12.57% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 204% |
| 1% | 207% |
| 2% | 210% |
| 3% | 213% |
| 4% | 216% |
| 5% | 219% |
Want more companies with a valuation profile/forecast similar to that of Cigna Corp? See PCRX, ALXN, AMEH, INVA, and SEM.
Loading social stream, please wait...